BioHarvest Sciences Inc.
BHST
$7.20
-$0.4621-6.03%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 74.76% | 98.77% | 111.68% | 115.57% | 127.71% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 74.76% | 98.77% | 111.68% | 115.57% | 127.71% |
| Cost of Revenue | 51.95% | 59.77% | 56.57% | 53.91% | 56.12% |
| Gross Profit | 98.04% | 147.51% | 202.35% | 246.72% | 328.17% |
| SG&A Expenses | 37.99% | 31.92% | 40.05% | 20.60% | 26.56% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 41.61% | 42.14% | 47.35% | 35.80% | 41.38% |
| Operating Income | 17.74% | 29.87% | 21.13% | 29.00% | 15.78% |
| Income Before Tax | 53.11% | -2.71% | -111.33% | -57.08% | -86.58% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 52.86% | -2.78% | -111.33% | -57.08% | -86.58% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 52.86% | -2.78% | -111.33% | -57.08% | -86.58% |
| EBIT | 17.74% | 29.87% | 21.13% | 29.00% | 15.78% |
| EBITDA | 25.40% | 35.46% | 26.09% | 32.87% | 17.56% |
| EPS Basic | 62.36% | 7.27% | -92.70% | -47.56% | -75.69% |
| Normalized Basic EPS | 62.54% | 7.31% | -92.75% | -47.59% | -75.68% |
| EPS Diluted | 62.36% | 7.27% | -92.70% | -47.56% | -75.69% |
| Normalized Diluted EPS | 62.54% | 7.31% | -92.75% | -47.59% | -75.68% |
| Average Basic Shares Outstanding | 25.13% | 19.53% | 16.28% | 9.56% | 4.85% |
| Average Diluted Shares Outstanding | 25.13% | 19.53% | 16.28% | 9.56% | 4.85% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |